Then, a company named Regeneron announced they would buy the company, and would “prioritize [consumer data's] privacy, ...

23andMe's co-founder and former chief executive, Anne Wojcicki, looks set to regain control of the business after emerging ...

Regeneron did not bid higher on the genetic testing company because of “its assessment of 23andMe’s remaining value,” ...

Beleaguered genetic testing company 23andMe announced Friday that it has reached an agreement to sell itself to TTAM Research ...

Added to that, 23andMe suffered a massive data breach in 2023 that resulted in information from about 7 million people being ...

Anne Wojcicki's nonprofit will acquire substantially all of 23andMe's assets for $305 million, the company announced Friday.

Regeneron Pharmaceuticals has declined to submit a new bid for genetic testing company 23andMe exceeding its original winning ...

Its co-founder and CEO ... Regeneron co-founder, board co-chair and Chief Scientific Officer George Yancopoulos said in a statement. Regeneron said Monday that it will comply with 23andMe's ...

The company’s co-founder and CEO ... Regeneron emphasized that it sees significant value in preserving and expanding 23andMe’s core mission of empowering individuals through genetic insights.

The fate of genetic data belonging to millions of 23andMe customers is again up in the air, as the bankrupt company seeks a judge’s permission to consider another bid from its co-founder and ...